Extraocular muscles (EOM) are characterised by their faster rates of contraction and their higher resistance to fatigue relative to limb skeletal muscles. One of the most perplexing issues in muscle physiology is why EOM generate significantly lower specific forces [sP o , force per muscle crosssectional area (CSA), kN/m 2 ] than skeletal muscles. In previous studies the examination of EOM contractility was generally performed on isolated muscles, in vitro. It is possible that during the intricate dissections required for in vitro investigation that surgical trauma results in damage directly to the EOM and this contributes to the disparity in sP o values between EOM and skeletal muscles. In this study, we have re-examined the issue of whether EOM produce lower sP o than skeletal muscles. Specifically, we have investigated the force producing capacity of the levator palpebrae superioris (levator) and superior rectus muscles, from the rat, in situ. We compared the values for absolute force (P o ) and sP o with those for muscles studied in vitro. We tested the null hypothesis, that the sP o for EOM obtained in situ would not be different from that of limb skeletal muscles. A corollary to our primary hypothesis was that P o and sP o for EOM obtained in situ and in vitro would not be different.
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For the evaluation of EOM function in situ, Sprague-Dawley rats (250-450 g) were anaesthetised deeply with sodium pentobarbitone of (60-80 mg kg -1 , i.p.) such that they did not respond to tactile stimuli throughout the procedures. During the intricate dissection procedures, nerve and blood supply to either the levator or the superior rectus muscle remained intact. The EOM were attached to a force transducer and the cranial nerves exposed for direct stimulation. After determination of optimal muscle length (L o ) and stimulation voltage, a full frequency-force relationship was established for each muscle. In separate experiments, the levator and superior rectus muscles were `excised for evaluation of isometric contractile function in vitro, using methods described in detail elsewhere (Lynch et al., 2000) . Animals were killed by cardiac excision whilst still anaesthetised. Maximum P o for the levator and superior rectus muscles was 177 ± 13 mN and 280 ± 10 mN, respectively. For the calculation of specific force, a number of rat levator and superior rectus muscles were partially digested in a 20% nitric acid-based solution in order to isolate individual muscle fibres. Muscle fibre lengths (L f ) were expressed as a percentage of overall muscle length, allowing a mean L f to L o ratio to be used in the estimation of muscle CSA. Mean L f :L o was determined to be 0.38 for the levator muscle and 0.45 for the superior rectus muscle. The sP o for the rat levator and superior rectus muscles measured in situ, was 275 kN/m 2 and 280 kN/m 2 , respectively. These values are within the range of sP o values commonly reported for rat skeletal muscles. Furthermore, P o and sP o for the levator and superior rectus muscles measured in situ were significantly higher (P < 0.001) than P o and sP o for these muscles measured in vitro.
The results indicate that the force output of intact EOM differs greatly depending on the mode of testing. In situ evaluation yields higher forces such that sP o values are similar to those for limb muscles. Most skeletal muscles develop similar forces in situ and in vitro, whereas EOM generate far less force in all studies performed in vitro. Although in vitro evaluation of EOM contractility will continue to reveal important information about this group of understudied muscles, the lower sP o values of these preparations should be recognised as being significantly less than their true potential. We conclude that EOM are not intrinsically weaker than skeletal muscles. 
